Effects of Feeding Schedule on the Development of ICU Delirium
Sponsor: Rutgers, The State University of New Jersey
Terminated
Trained study staff left the study and we had difficulty recruiting patients.
Other terminated trials from Rutgers, The State University of New Jersey
- Pain Management · Phase PHASE4 · Dec 2024
- Breast Cancer · Phase NA · Aug 2023
- Muscle Soreness · Phase NA · Jun 2022
- Other Biomechanical Lesions of Upper Extremity · Phase NA · Mar 2021
- Covid19 · Phase PHASE2 · Feb 2021
See all terminations from Rutgers, The State University of New Jersey
This NA trial investigates ICU Delirium and is currently terminated or withdrawn. Rutgers, The State University of New Jersey leads this study, which shows 7 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Dec 2024 — Present [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Sep 2024 — Dec 2024 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
May 2024 — Jul 2024 [monthly]
Recruiting NA
-
Jul 2022 — May 2024 [monthly]
Recruiting NA
▶ Show 2 earlier versions
-
Sep 2021 — Jul 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jun 2021 — Sep 2021 [monthly]
Not Yet Recruiting NA
First recorded
Apr 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Rutgers, The State University of New Jersey
For direct contact, visit the study record on ClinicalTrials.gov .